• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2007 Fiscal Year Final Research Report Summary

Research on a highly-efficient and tumor-specific gene therapy using autologous NK/NKT cells as gene carriers

Research Project

Project/Area Number 18592200
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Surgical dentistry
Research InstitutionShowa University

Principal Investigator

ITO Daisuke  Showa University, School of Dentistry, Associate Professor (40286844)

Co-Investigator(Kenkyū-buntansha) IWASE Masayasu  Showa University, School of Dentistry, Associate Professor (50193743)
ODANI Takeshi  Showa University, School of Dentistry, Research Fellow (40407440)
Project Period (FY) 2006 – 2007
KeywordsNK cells / mouse / tumor transplantation model / P16INK4 / B16F10 / 3LL
Research Abstract

We examined the population of tumor infiltrating cells in the experimental primary tumor model where 3LL or B16F10 cells were injected to the lateral flank of C57BL6 mice. A number of infiltrating cells were found around the 3LL tumor. The majority of these cells were CD3+/NK1.1- Trills and neutrophils, and the remaining includes NK cells and MHC class II+ cells (macrophages and dendritic cells).
Murine splenocytes were obtained and cultured for seven days in the presence ofIL-2/1, -12. The proportion of NK1.1+CD3- cells was elevated from a few % to 10-15% after the culture. These cultured splenocytes were injected around the 3LL or B16 tumors (approximately 10 mm in diameter) and the tumor infiltrating cells were immunohistochemically observed. Marked infiltration of NK1.1+CD3- cells was found in the peritumoral tissue within 48 hours after the splenocyte infection. Similar results were obtained from cultured bone marrow cells of Thalidomide-treated mice.
Then the expression of p16INK4 in the tumor cell lines was examined by RTPCR and Western immunoblotting. mRNA expression of p16INK4 was observed in the both cells, but its protein expression was almost under the detectable level. Full length cDNA of p16INK4 was obtained by cDNA cloning, and inserted to a plasmid expression vector. A detectable expression was observed in the p16INK4-transfectant of 3LL and B16F10. p16INK4 overexpression resulted in a marked growth suppression of these cell lines. Now we are working for the construction of p16INK4 adenovirous vector and performing preliminary experiments using another adenovirus vector on the transport of the vectors by murine NK cells in vitro.

  • Research Products

    (11 results)

All 2008 2007 2006 Other

All Journal Article (9 results) (of which Peer Reviewed: 3 results) Presentation (2 results)

  • [Journal Article] Enhanced susceptibility of apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors2007

    • Author(s)
      Iwase, M, et. al.
    • Journal Title

      Int J Oncol 31(5)

      Pages: 1141-1147

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Thalidomide suppresses melanoma growth by activating NK cells in mice2006

    • Author(s)
      Kawamata A, Ito D, et. al.
    • Journal Title

      Oncology Reports 16

      Pages: 1231-1236

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Gene expression profiles of oral leukoplakia and carcinoma:A genome-wide comparison analysis using an oligonucleotide microarray technology2006

    • Author(s)
      Odani T, Ito D, et. al.
    • Journal Title

      International Journal of Oncology 28

      Pages: 619-624

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] 化学誘発性マウス口腔粘膜上皮性異形成におけるtransglutaminase-3の発現変化2006

    • Author(s)
      伊東 大典, 磯辺 友秀, 他
    • Journal Title

      日本口腔粘膜学会雑誌 12(2)

      Pages: 51-58

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Gene expression profiles of oral leukoplakia and carcinoma : A genome-wide comparison analysis using an oligonucleotide microarray technology2006

    • Author(s)
      Odani, T, Ito, D, et. al.
    • Journal Title

      Int J Oncol 28

      Pages: 619-624

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Thalidomide suppresses melanoma growth by activating natural killer cells in mice2006

    • Author(s)
      Kawamata, A, Ito, D, et. al.
    • Journal Title

      Oncol Rep 16

      Pages: 1231-1236

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] A case of bullous pemphigoid initially occurred in the oral cavity2006

    • Author(s)
      Ito, D, et. al.
    • Journal Title

      J Jpn Assoc Oral Muc Membr 12(1)

      Pages: 30-35

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Changes in the expression of transglutaminase-3 in the chemically-induced oral epithelial dysplasia2006

    • Author(s)
      Ito, D, et. al.
    • Journal Title

      J Jpn Assoc Oral Muc Membr 12(2)

      Pages: 51-58

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G1 phase cell cycle arrest

    • Author(s)
      Yoshiba, S, Ito, D, et. al.
    • Journal Title

      Oral Oncology (in press)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] Hypoxia induces resistance to 5-FU in oral cancer cells via G1 phase cell cycle arrest2008

    • Author(s)
      Yoshiba S, Ito D, et. al.
    • Organizer
      Annual Meeting of the AACR
    • Place of Presentation
      San Diego,USA
    • Year and Date
      20080400
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G1 phas cell cycle arrest2008

    • Author(s)
      Yoshiba, S, Ito, D, et. al.
    • Organizer
      Annual Meeting of AACR
    • Place of Presentation
      San Diego
    • Year and Date
      20080400
    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2010-02-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi